Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29627410 | 1.00 | GRM5 (0.46) | GRM5NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL29627397 | 0.86 | NPC1 (0.50) | GRM5NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL24539680 | 0.83 | HPGD (0.44) | RAB9AKDM4ELMNAMAPTTP53 | |
| SCHEMBL24539603 | 0.72 | MEN1 (0.49) | NPC1RAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL29627416 | 0.72 | MEN1 (0.49) | NPC1RAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL1399929 | 0.68 | NPC1 (0.62) | NPC1RAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL5139794 | 0.68 | RAB9A (0.65) | GRM5NPC1RAB9AALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL27440821 | 0.67 | RAB9A (0.64) | GRM5NPC1RAB9AALDH1A1LMNA | |
| SCHEMBL27488058 | 0.66 | L3MBTL1 (0.64) | GRM5NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL27488421 | 0.66 | RAB9A (0.63) | GRM5NPC1RAB9AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612358-B2 | Resorcinol-based compounds and uses thereof | SUTTER BAY HOSPITALS (US) | 2026-04-28 | — | — | US | disclosed |
| US-20240059646-A1 | RESORCINOL-BASED COMPOUNDS AND USES THEREOF | ORGANIX INC. | 2024-02-22 | — | — | US | disclosed |
| WO-2022133058-A1 | RESORCINOL-BASED COMPOUNDS AND USES THEREOF | SUTTER BAY HOSPITALS (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022133058-A1 | RESORCINOL-BASED COMPOUNDS AND USES THEREOF | SUTTER BAY HOSPITALS (US) | 2022-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612358-B2 | Resorcinol-based compounds and uses thereof | CARM1, MALT1, RCOR1 | GRM5 2211/4885NPC1 72/4885RAB9A 1130/4885 |
| US-20240059646-A1 | RESORCINOL-BASED COMPOUNDS AND USES THEREOF | VHL, NQO1, HRAS | GRM5 1485/4885NPC1 132/4885RAB9A 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.